Related Experiment Video
Updated: Jul 20, 2026

Analysis of Minerals Produced by hFOB 1.19 and Saos-2 Cells Using Transmission Electron Microscopy with Energy Dispersive X-ray Microanalysis
Published on: June 24, 2018
Erk pathways negatively regulate matrix mineralization
Shin-jiro Kono1, Yasushi Oshima, Kazuto Hoshi
1Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Tokyo 113-0033, Japan.
Abstract:
Skeletal mineralization is an important step regulating the mechanical properties of the calcified tissues, but molecular events underlying mineralization still remain elusive. We examined the role of extracellular signal-regulated kinase (Erk) pathways in matrix mineralization of osteogenic cells both in vitro and in vivo. Matrix mineralization by preosteocytic MLO-A5 cells and osteoblastic MC3T3-E1 cells was increased by either PD98059 Mek inhibitor treatment or adenovirus vector-mediated dominant negative Ras (Ras(DN)) expression and was suppressed by Erk activation by platelet-derived growth factor (PDGF) treatment or constitutively active Mek1 (Mek(CA)) expression. Administration of adenovirus vectors carrying Ras(DN) gene onto the calvaria of 1-day-old mice increased the mineralization of the tissues, while that of the Mek(CA) adenovirus suppressed it. These results suggest that the Erk pathway is a negative regulator of the matrix mineralization both in vitro and in vivo.
Insights
The extracellular signal-regulated kinase (Erk) pathway negatively regulates skeletal matrix mineralization. Inhibiting Erk enhances bone mineralization, while activating it suppresses this crucial process.
Area of Science:
- Biochemistry
- Cell Biology
- Skeletal Biology
Background:
- Skeletal mineralization is vital for tissue mechanical properties.
- The molecular mechanisms controlling skeletal mineralization are not fully understood.
Purpose of the Study:
- To investigate the role of extracellular signal-regulated kinase (Erk) pathways in matrix mineralization.
- To determine if Erk acts as a positive or negative regulator of osteogenic matrix mineralization.
Main Methods:
- In vitro studies using osteogenic cell lines (MLO-A5, MC3T3-E1) treated with Erk pathway modulators (PD98059, PDGF, Ras(DN), Mek(CA)).
- In vivo studies involving adenovirus vector-mediated gene delivery (Ras(DN), Mek(CA)) to mouse calvaria.
Main Results:
- Erk pathway inhibition (PD98059, Ras(DN)) increased matrix mineralization in osteogenic cells.
- Erk pathway activation (PDGF, Mek(CA)) suppressed matrix mineralization.
- In vivo administration of Ras(DN) enhanced calvarial mineralization, while Mek(CA) suppressed it.
Conclusions:
- The extracellular signal-regulated kinase (Erk) pathway acts as a negative regulator of matrix mineralization.
- Modulating the Erk pathway offers potential therapeutic targets for skeletal mineralization disorders.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Bone Matrix
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Remodeling
Non-Canonical Wnt Signaling Pathways
